Altreos Research Partners

Altreos Research Partners is a specialized clinical research organization (CRO) and consultancy focused on the assessment of the abuse potential of CNS-active drugs. Founded by recognized leaders in the field, the company provides strategic, regulatory, and operational expertise for Human Abuse Potential (HAP) studies, which are critical for the scheduling and labeling of new medications. Their services include study design, protocol development, data analysis, and representation at regulatory meetings with the FDA and other agencies. By bridging the gap between clinical pharmacology and regulatory requirements, Altreos helps pharmaceutical sponsors navigate the complex landscape of drug abuse liability assessment. In 2015, the company was acquired by INC Research (now Syneos Health) to bolster its specialized CNS clinical development capabilities.